Nicolas Sayegh, Ryon P. Graf, Julia Quintanilha, Douglas I. Lin, Jeffrey S. Ross, Julia A. Elvin, Zeynep Irem Ozay, Umang Swami, Rana R. McKay, Tian Zhang, Alan Haruo Bryce, Neeraj Agarwal. "Additive clinical utility of tissue biomarkers of microsatellite instability (MSI) status and tumor mutational burden (TMB) to predict immune checkpoint inhibitor (ICI) effectiveness for real-world patients with metastatic castration-resistant prostate cancer (mCRPC).." Journal of Clinical Oncology, 2025. doi:10.1200/jco.2025.43.16_suppl.5064